TREATMENT READING
Mycosis Fungoides and Other Cutaneous T-Cell Lymphomas
Choose a source section by treatment, subtype or setting. Patient and professional reading are labelled separately.
Selected text from the National Cancer Institute, with original links and dates. This Triangle reading page is not an NCI PDQ summary. Source topics may be broader than an individual diagnosis.
2 studies cited in this topic · see design and results →
Certain factors affect prognosis (chance of recovery) and treatment options.
Mycosis fungoides and Sézary syndrome can recur (come back) after they have been treated.
Treatment Option Overview
Key Points
There are different types of treatment for patients with mycosis fungoides and cancer.
Seven types of standard treatment are used:
Photodynamic therapy
Radiation therapy
Chemotherapy
Other drug therapy
Immunotherapy
Targeted therapy
High-dose chemotherapy and radiation therapy with stem cell transplant
New types of treatment are being tested in clinical trials.
Immune checkpoint inhibitor therapy
Treatment for mycosis fungoides and Sézary syndrome may cause side effects.
Patients may want to think about taking part in a clinical trial.
Patients can enter clinical trials before, during, or after starting their cancer treatment.
Follow-up tests may be needed.
Treatment of Stage I and Stage II Mycosis Fungoides
Treatment of Stage III and Stage IV Mycosis Fungoides (Including Sézary Syndrome)
Treatment Recurrent Mycosis Fungoides (Including and Sézary Syndrome)
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle